Search Results

Roquinimex 25 mg  | 99.65%

TargetMol

Roquinimex (Linomide) is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity; inhibits angiogenesis and reduces the secretion of TNF alpha.

More Information Supplier Page

Roquinimex 50 mg  | 99.65%

TargetMol

Roquinimex (Linomide) is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity; inhibits angiogenesis and reduces the secretion of TNF alpha.

More Information Supplier Page

Roquinimex 100 mg  | 99.65%

TargetMol

Roquinimex (Linomide) is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity; inhibits angiogenesis and reduces the secretion of TNF alpha.

More Information Supplier Page

Biapenem 25 mg  | 97.83%

TargetMol

Biapenem is a 1-beta-methylcarbapenem antibiotic with a wide range of antibacterial activity. Biapenem has similar antibacterial activity to that of imipenem, but is more stable against human renal dehydropeptidase-I and with less neurotoxicity.

More Information Supplier Page

Anacardic Acid 5 mg  | 97.47%

TargetMol

Anacardic Acid is an effective inhibitor of p300 and p300/CBP-associated factor histone acetyltranferases. It also has antimicrobial activity, antibacterial activity, and inhibits prostaglandin synthase, lipoxygenase, and tyrosinase.

More Information Supplier Page

PD318088 1 mg  | 99.81%

TargetMol

PD318088 is a non-ATP competitive allosteric MEK1/2 inhibitor, binding simultaneously with ATP in a region of the MEK1 active site that is adjacent to the ATP-binding site.

More Information Supplier Page

IMD-0354 100 mg  | 99.56%

TargetMol

IMD-0354 (IKK2 Inhibitor V) is an IKKβ inhibitor and inhibits IκBα phosphorylation in NF-κB pathway.

More Information Supplier Page